. . . . . . . . . "indications based on a review of this drug by the national academy of sciences national research council and or other information fda has classified the indications as follows effective management of nausea and vomiting and dizziness associated with motion sickness possibly effective management of vertigo associated with diseases affecting the vestibular system final classification of the less than effective indications required further investigation" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "LUOlIi5q9GskobVu67guoxiALMVgIQyOptcXKp+nxgYhXUA8+NSVB/Et1C3kfD7t1hpjwHv8xCOF9XATuccArAWu01Gs+coF5HT2wrDJ3rMAnkkm6KHmqjGua4gi53Qxhl2ZOT4TiVyy3MAKyeZWkkXe2DN/JjVNh9i+xmAb8dg=" . . "2021-07-03T13:09:03.628+02:00"^^ . . . . .